Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000897069-25-001547
Filing Date
2025-10-03
Accepted
2025-10-03 16:27:52
Documents
1
Period of Report
2025-10-01

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5990
  Complete submission text file 0000897069-25-001547.txt   7548
Mailing Address 15 TRANQUILITY PLACE LADERA RANCH CA 92694
Business Address
SKIBSTED RUSSELL (Reporting) CIK: 0001308105 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39531 | Film No.: 251374301

Mailing Address 601 21ST STREET, SUITE 300 VERO BEACH FL 32960
Business Address 601 21ST STREET, SUITE 300 VERO BEACH FL 32960 443-776-3133
Processa Pharmaceuticals, Inc. (Issuer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)